# Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis

> **NCT01979900** · PHASE3 · COMPLETED · sponsor: **Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.** · enrollment: 10000 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** Vaccae
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01979900
- **Lead sponsor:** Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2017-11-26
- **Final completion:** 2017-11-26
- **Target enrollment:** 10000 (ACTUAL)
- **Last updated:** 2018-06-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01979900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01979900, "Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01979900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*